These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 8676203

  • 21. Survival and DNA damage in Chinese hamster V79 cells exposed to alpha particles emitted by DNA-incorporated astatine-211.
    Walicka MA, Vaidyanathan G, Zalutsky MR, Adelstein SJ, Kassis AI.
    Radiat Res; 1998 Sep; 150(3):263-8. PubMed ID: 9728654
    [Abstract] [Full Text] [Related]

  • 22. 5-[211 At]astato-2'-deoxyuridine, an alpha particle-emitting endoradiotherapeutic agent undergoing DNA incorporation.
    Vaidyanathan G, Larsen RH, Zalutsky MR.
    Cancer Res; 1996 Mar 15; 56(6):1204-9. PubMed ID: 8640798
    [Abstract] [Full Text] [Related]

  • 23. The nucleus is the target for radiation-induced chromosomal instability.
    Kaplan MI, Morgan WF.
    Radiat Res; 1998 Oct 15; 150(4):382-90. PubMed ID: 9768851
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Specific killing of human melanoma cells by 125I-labeled 9.2.27 monoclonal antibody.
    Lindmo T, Boven E, Mitchell JB, Morstyn G, Bunn PA.
    Cancer Res; 1985 Oct 15; 45(10):5080-7. PubMed ID: 4027987
    [Abstract] [Full Text] [Related]

  • 27. Radiotoxicity of 5-[123I]iodo-2'-deoxyuridine in V79 cells: a comparison with 5-[125I]iodo-2'-deoxyuridine.
    Makrigiorgos GM, Kassis AI, Baranowska-Kortylewicz J, McElvany KD, Welch MJ, Sastry KS, Adelstein SJ.
    Radiat Res; 1989 Jun 15; 118(3):532-44. PubMed ID: 2727274
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Impact of IUdR on Rat 9L glioma cell survival for 25-35 keV photon-activated auger electron therapy.
    Alvarez D, Hogstrom KR, Brown TA, Ii KL, Dugas JP, Ham K, Varnes ME.
    Radiat Res; 2014 Dec 15; 182(6):607-17. PubMed ID: 25409122
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Probabilistic modeling of DNA mismatch repair effects on cell cycle dynamics and iododeoxyuridine-DNA incorporation.
    Gurkan E, Schupp JE, Aziz MA, Kinsella TJ, Loparo KA.
    Cancer Res; 2007 Nov 15; 67(22):10993-1000. PubMed ID: 18006845
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effects of DNA-targeted ionizing radiation produced by 5-[125I]iodo-2'-deoxyuridine on global gene expression in primary human cells.
    Sokolov MV, Neumann RD, Panyutin IG.
    BMC Genomics; 2007 Jun 26; 8():192. PubMed ID: 17594496
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. 5-[123I/125I]iodo-2'-deoxyuridine in metastatic lung cancer: radiopharmaceutical formulation affects targeting.
    Semnani ES, Wang K, Adelstein SJ, Kassis AI.
    J Nucl Med; 2005 May 26; 46(5):800-6. PubMed ID: 15872354
    [Abstract] [Full Text] [Related]

  • 37. A cell kinetic method for the mitotic selection of treated G2 cells.
    Schneiderman MH, Schneiderman GS, Rusk CM.
    Cell Tissue Kinet; 1983 Jan 26; 16(1):41-9. PubMed ID: 6825155
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A balanced deoxyribonucleoside mixture increased the rate of DNA incorporation of 5-[125I]Iodo-2'-deoxyuridine in glioblastoma cells.
    Dupertuis YM, Buchegger F, Pichard C.
    Cancer Biother Radiopharm; 2003 Feb 26; 18(1):7-16. PubMed ID: 12667304
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.